Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)
Stopped The study was terminated due to insufficient subject enrollment and very slow enrollment.
Conditions
- Indolent Non Hodgkin's Lymphoma (iNHL)
- Chronic Lymphocytic Leukaemia (CLL)
Sponsor
Astellas Pharma International B.V.